MEDICINE DETAILS
Livtencity
Active ingredient: Maribavir
Livtencity is recorded in this directory with the active ingredient Maribavir. This page brings together catalogue strength, dosage-form and pack records so they can be checked against a prescription.
NEXT STEP
Choose the strength and pack
✓ If you are unsure, choose “I do not know”.
These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.
ABOUT THIS MEDICINE
What is Livtencity used for?
Livtencity (maribavir) is a cytomegalovirus (CMV) pUL97 kinase inhibitor indicated to treat adults and children (12 years of age and older and weighing at least 35 kg) with post-transplant cytomegalovirus (CMV) infection/disease that is refractory to treatment (with or without genotypic resistance) with ganciclovir, valganciclovir, cidofovir, or foscarnet.
It is available in tablet form, each containing 200 mg maribavir.
This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.
RECORDED PRODUCT PROFILE
Livtencity identity, dosage form and pack information.
The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.
Recorded strength and pack options
Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.
-
200 mg · 28 tablets Catalogue organisation: TAKEDA GmbH
-
200 mg · 56 tablets Catalogue organisation: TAKEDA GmbH
-
200 mg · 112 tablets Catalogue organisation: TAKEDA GmbH
OFFICIAL SOURCES
Check the Livtencity record at an official source.
Search for “Livtencity” or “Maribavir”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.
OFFICIAL EXTERNAL SOURCE
European Medicines Agency (EMA)
Search medicines evaluated by EMA by brand name or active substance. EMA also links to national registers for nationally authorised products.
↗ OFFICIAL EXTERNAL SOURCE Drugs@FDASearch FDA-approved human drug records by brand name or active ingredient, including current labelling where available.
↗SERVICE BOUNDARY
Information checking and independent enquiry support for Livtencity.
OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.
Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.
CLEAR ANSWERS
Frequently asked questions about Livtencity
01What is Livtencity?＋
This directory record associates the brand name Livtencity with the active ingredient Maribavir. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.
02Which Livtencity strengths and packs are recorded?＋
The catalogue currently shows: 200 mg · 28 tablets; 200 mg · 56 tablets; 200 mg · 112 tablets. Check the complete strength, dosage form and pack description against the prescription and medicine box.
03Who manufactures Livtencity?＋
Catalogue records currently name: TAKEDA GmbH. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.
04Do the listed options confirm stock or access?＋
No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.
05What affects a possible estimated medicine cost for Livtencity?＋
A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Livtencity, payment request, stock guarantee or binding offer.
06Can I buy Livtencity from this website?＋
No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.